209 related articles for article (PubMed ID: 34335982)
1. N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application.
Song HE; Lee Y; Kim E; Cho CY; Jung O; Lee D; Lee EG; Nam SH; Kang M; Macalino SJY; Kim JE; Jung JW; Kwon SW; Choi S; Lee JW
Theranostics; 2021; 11(16):8092-8111. PubMed ID: 34335982
[TBL] [Abstract][Full Text] [Related]
2. The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation.
Jung O; Choi YJ; Kwak TK; Kang M; Lee MS; Ryu J; Kim HJ; Lee JW
Biochim Biophys Acta; 2013 Mar; 1833(3):629-42. PubMed ID: 23220047
[TBL] [Abstract][Full Text] [Related]
3. Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells.
Jung O; Choi S; Jang SB; Lee SA; Lim ST; Choi YJ; Kim HJ; Kim DH; Kwak TK; Kim H; Kang M; Lee MS; Park SY; Ryu J; Jeong D; Cheong HK; Kim HJ; Park KH; Lee BJ; Schlaepfer DD; Lee JW
J Cell Sci; 2012 Dec; 125(Pt 24):5960-73. PubMed ID: 23077174
[TBL] [Abstract][Full Text] [Related]
4. CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).
Kim S; Cho CY; Lee D; Song DG; Kim HJ; Jung JW; Kim JE; Park D; Lee H; Um H; Park J; Choi Y; Kim Y; Nam SH; Lee JW
Cancer Lett; 2018 Dec; 438():219-231. PubMed ID: 30217560
[TBL] [Abstract][Full Text] [Related]
5. Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity.
Choi S; Lee SA; Kwak TK; Kim HJ; Lee MJ; Ye SK; Kim SH; Kim S; Lee JW
Blood; 2009 Feb; 113(8):1845-55. PubMed ID: 19036703
[TBL] [Abstract][Full Text] [Related]
6. Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
Lee D; Na J; Ryu J; Kim HJ; Nam SH; Kang M; Jung JW; Lee MS; Song HE; Choi J; Lee GH; Kim TY; Chung JK; Park KH; Kim SH; Kim H; Seo H; Kim P; Youn H; Lee JW
Hepatology; 2015 Jun; 61(6):1978-97. PubMed ID: 25627085
[TBL] [Abstract][Full Text] [Related]
7. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
[TBL] [Abstract][Full Text] [Related]
8. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities.
Kang M; Ryu J; Lee D; Lee MS; Kim HJ; Nam SH; Song HE; Choi J; Lee GH; Kim TY; Lee H; Kim SJ; Ye SK; Kim S; Lee JW
PLoS One; 2014; 9(7):e102817. PubMed ID: 25033048
[TBL] [Abstract][Full Text] [Related]
9. TM4SF5-mediated protein-protein networks and tumorigenic roles.
Lee JW
BMB Rep; 2014 Sep; 47(9):483-7. PubMed ID: 25027595
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between the TM4SF5/focal adhesion kinase and the interleukin-6/STAT3 pathways promotes immune escape of human liver cancer cells.
Ryu J; Kang M; Lee MS; Kim HJ; Nam SH; Song HE; Lee D; Lee JW
Mol Cell Biol; 2014 Aug; 34(16):2946-60. PubMed ID: 24912675
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody targeting of the cell surface molecule TM4SF5 inhibits the growth of hepatocellular carcinoma.
Kwon S; Choi KC; Kim YE; Ha YW; Kim D; Park BK; Wu G; Kim DS; Lee Y; Kwon HJ
Cancer Res; 2014 Jul; 74(14):3844-56. PubMed ID: 24802189
[TBL] [Abstract][Full Text] [Related]
12. Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44.
Lee D; Lee JW
BMB Rep; 2015 Mar; 48(3):127-8. PubMed ID: 25772760
[TBL] [Abstract][Full Text] [Related]
13. Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.
Ahn HM; Ryu J; Song JM; Lee Y; Kim HJ; Ko D; Choi I; Kim SJ; Lee JW; Kim S
Theranostics; 2017; 7(3):594-613. PubMed ID: 28255353
[TBL] [Abstract][Full Text] [Related]
14. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
Fan G; Aleem S; Yang M; Miller WT; Tonks NK
J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of transmembrane 4 L six family member 5 (TM4SF5)-mediated tumorigenesis by TSAHC and sorafenib.
Lee SA; Lee MS; Ryu HW; Kwak TK; Kim H; Kang M; Jung O; Kim HJ; Park KH; Lee JW
Cancer Biol Ther; 2011 Feb; 11(3):330-6. PubMed ID: 21099346
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of cellular functions by the C-termini of transmembrane 4 L six family proteins in 2- or 3-dimensional environment.
Cheong JG; Song DG; Song HE; Berditchevski F; Nam SH; Jung JW; Kim HJ; Kim JE; Kim S; Ryu J; Cho CY; Lee KM; Lee JW
Oncotarget; 2017 Feb; 8(8):13277-13292. PubMed ID: 28129652
[TBL] [Abstract][Full Text] [Related]
17. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14).
Lee H; Woodman SE; Engelman JA; Volonté D; Galbiati F; Kaufman HL; Lublin DM; Lisanti MP
J Biol Chem; 2001 Sep; 276(37):35150-8. PubMed ID: 11451957
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated overexpression of C-terminal Src kinase (Csk) in type I astrocytes interferes with cell spreading and attachment to fibronectin. Correlation with tyrosine phosphorylations of paxillin and FAK.
Takayama Y; Tanaka S; Nagai K; Okada M
J Biol Chem; 1999 Jan; 274(4):2291-7. PubMed ID: 9890993
[TBL] [Abstract][Full Text] [Related]
19. beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis.
Miller WE; Maudsley S; Ahn S; Khan KD; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2000 Apr; 275(15):11312-9. PubMed ID: 10753943
[TBL] [Abstract][Full Text] [Related]
20. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
